Literature DB >> 20444517

Insulin pump access issues for visually impaired people with type 1 diabetes.

Lorraine Marom1.   

Abstract

BACKGROUND: An electronic literature search was conducted to determine suitability of insulin pumps for people with type 1 diabetes who have visual impairment.
METHODS: Ovid MEDLINE and CINAHL databases as well as the Internet were searched. Search terms used were insulin pump therapy, continuous subcutaneous insulin infusion, blindness, vision disorders, visually impaired persons and low vision. Only two relevant articles were identified regarding accessibility issues for insulin pump use by vision-impaired people with diabetes.
RESULTS: Insulin pumps currently available do not have features that are sufficiently compatible with severely visually impaired people. None have speech output, user guides in Braille or accessible diabetes software for personal computers and only one pump has good visual display characteristics.
CONCLUSIONS: As serious health consequences can result from improper use of insulin pumps, industry should design pumps with features that can be safely and easily accessed by people with severe vision loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444517     DOI: 10.1016/j.diabres.2010.04.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

Review 1.  Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind.

Authors:  Lutz Heinemann; Diana Drossel; Guido Freckmann; Bernhard Kulzer
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

2.  Equity in the Provision of Diabetes Self-Management Education and Support.

Authors:  Julia E Blanchette; Siobhan P Aaron; Nancy A Allen; Michelle L Litchman
Journal:  Diabetes Spectr       Date:  2022-08-15

3.  Continuous Glucose Monitor with Siri Integration Improves Glycemic Control in Legally Blind Patients with Diabetes.

Authors:  H Kaan Akturk; Janet K Snell-Bergeon; Viral N Shah
Journal:  Diabetes Technol Ther       Date:  2020-07-30       Impact factor: 6.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.